Immunity Acceptance Rate

Cell Press does not publish an official acceptance rate for Immunity.

Third-party aggregators report varying estimates, but none have been confirmed by the publisher. The journal publishes monthly, covering the full breadth of immunology - innate, adaptive, mucosal, tumor, and systems immunology - which is consistent with moderate-to-high selectivity, but the exact rate is not public.

What is stable is the editorial model:

• Cell Press uses professional PhD-trained editors with immunology backgrounds who triage rapidly
• the journal covers the full discipline: innate, adaptive, mucosal, tumor, systems, and computational immunology
• mechanistic insight is required - descriptive studies and surveys of immune responses are not sufficient
• the editorial team values in vivo evidence, human validation where possible, and multi-model support

That breadth plus mechanistic rigor is the real editorial filter.

At triage, the editor is usually asking:

• does this study reveal how an immune process works, not just that it happens?
• is the finding broadly significant across immunology, or is it highly specialized to one narrow niche?
• does the evidence include functional experiments - knockouts, perturbations, reconstitution - not just profiling?
• would both innate and adaptive immunologists find this paper worth reading?

Papers that demonstrate mechanism through functional evidence will survive triage more reliably than papers built primarily on flow cytometry profiles or sequencing surveys.

For Immunity, the useful question is:

Does this study reveal an immunological mechanism with broad significance across the discipline?

If yes, the journal is a strong fit. If the paper is primarily descriptive, purely correlative, or relevant only to a narrow immunological niche, the acceptance rate is not the constraint. The mechanistic breadth is.

The common misses are:

• centering strategy around an unofficial percentage instead of checking mechanistic depth
• submitting descriptive immune profiling studies without functional follow-up
• presenting single-model data without validation in human samples or independent systems
• treating the journal as interchangeable with Nature Immunology without considering reviewer pool differences
• submitting clinical immunology or vaccine studies when the mechanistic insight is thin

Those are mechanism and breadth problems before they are rate problems.

If you are deciding whether to submit, these pages are more useful than an unofficial rate:

• Immunity cover letter
• Immunity submission process
• Immunity submission guide
• Nature Immunology acceptance rate (the Springer Nature flagship)
• Frontiers in Immunology acceptance rate (broader, higher acceptance)

Together, they tell you whether the paper has enough mechanistic breadth, whether the editorial timeline is manageable, and whether a different immunology venue would be a cleaner fit.

In our pre-submission review work evaluating manuscripts targeting Immunity, three patterns generate the most consistent desk rejections. Each reflects the journal's standard: mechanistic immunological insight with broad disciplinary significance, functional evidence, and multi-system support.

Immune profiling study without functional mechanism. Immunity's editorial bar explicitly requires mechanistic insight, not observational characterization. The failure pattern is a paper using mass cytometry, scRNA-seq, CITE-seq, or spatial transcriptomics to characterize immune cell populations, states, or trajectories in a disease cohort, a specific tissue, or a treatment context, reporting accurate and high-quality immunological data, without functional experiments asking what the characterized cell types or states are actually doing. A paper showing that a specific effector T cell state is enriched in responders versus non-responders to immunotherapy, that a myeloid cell subpopulation is expanded in autoimmune disease, or that a tissue-resident lymphocyte population has a distinct transcriptomic signature, generates immunological observations without establishing the mechanism those observations represent. Cell Press editors redirect these papers to JEM, Journal of Immunology, or specialized immunology journals, with feedback that the mechanistic layer is absent.

Finding with narrow subdisciplinary relevance that does not generalize across immunology. Immunity covers the full breadth of the discipline, and the editors assess whether the cross-disciplinary readership would find the paper worth reading. The failure pattern is a mechanistically rigorous paper addressing a specific immunological question with deep expertise and strong data, where the biological context is sufficiently specialized that the finding matters primarily to a small community within immunology: a paper on a regulatory mechanism in a rare NKT cell subset, a signaling pathway in a specific innate lymphoid cell population in a niche tissue, or an antigen-specific response in a narrow infection model. These papers may be excellent science with important findings for specialists, but the Immunity editorial team asks whether the mechanism reveals something about how the immune system works that a T cell biologist, an innate immunologist, and a tumor immunologist would all find relevant. When the answer is no, the paper belongs in a focused venue.

Mechanistic conclusions from a single model system without independent validation. Immunity places high value on mechanistic claims that hold across independent evidence streams. The failure pattern is a paper that uses one genetic mouse model (a single conditional knockout or transgenic strain) as the primary evidence platform, with well-executed functional experiments in that model, but without corroboration from a complementary genetic approach, a pharmacologic intervention, a second mouse model background, human immune cell data, or an in vitro reconstitution. When the mechanistic conclusion depends entirely on the behavior of one genetic model, reviewers ask whether the phenotype is specific to the genetic manipulation or reflects the actual immunological mechanism. Papers that add a complementary approach, even a pharmacologic inhibitor of the same pathway or a second genetic model with independently validated phenotype, substantially strengthen their triage position. A Immunity submission readiness check can assess whether the mechanistic evidence package meets Immunity's standard before submission.

The honest answer to "what is the Immunity acceptance rate?" is that Cell Press does not publish one, and third-party estimates should not be treated as precise.

The useful answer is:

• yes, this is among the most selective immunology journals in the world
• no, a guessed percentage is not the right planning tool
• use immunological mechanism, functional evidence, and cross-discipline breadth as the real filter instead

If you want help pressure-testing whether this manuscript is positioned for an Immunity submission before upload, a Immunity submission readiness check is the best next step.

The acceptance rate for Immunity does not distinguish between desk rejections and post-review rejections. A paper desk-rejected in 2 weeks and a paper rejected after 4 months of review both count the same. The rate also does not reveal how acceptance varies by article type, geographic origin, or research area within the journal's scope.

Acceptance rates cannot predict your individual odds. A strong paper with clear scope fit, complete data, and solid methodology has substantially better odds than the headline number suggests. A weak paper with methodology gaps will be rejected regardless of the journal's overall rate.

A Immunity submission readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.